Drug profile · INN
insulin degludec
RYZODEG
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
insulin degludec (RYZODEG) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN insulin degludec
Brand RYZODEG
Route SUBCUTANEOUS
Formulation SOLUTION
ATC code A10AE06
Frequently asked questions
What is insulin degludec?
insulin degludec (RYZODEG) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for insulin degludec?
RYZODEG is a marketed brand name for insulin degludec. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of insulin degludec?
insulin degludec has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.